Methods and kits for amplifying DNA

• US 7,713,697 B2
• Filed: 03/01/2007
• Issued: 05/11/2010
• Est. Priority Date: 08/27/2004
• Status: Active Grant

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Inventors: Livezey, Kristin W., Becker, Michael M., Lam, Wai-Chung
• Primary Examiner(s): Horlick; Kenneth R.
• Assistant Examiner(s): Thomas; David C
• Application Number:
  US11/681,104
• Publication Number:
  US 20070202523A1
• Time in Patent Office: 1,167 Days
• Field of Search: None
• US Class Current: 435/6.12
• CPC Class Codes: C12P 19/34 Polynucleotides, e.g. nucleic acids, oligoribonucleotides
• CPC Class Codes: C12Q 1/6865 Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
• CPC Class Codes: C12Q 2521/107 RNA dependent DNA polymerase,(i.e. reverse transcriptase)
• CPC Class Codes: C12Q 2521/325 Single stranded exonuclease
• CPC Class Codes: C12Q 2525/143 incorporating a promoter sequence
• CPC Class Codes: C12Q 2525/186 incorporating a non-extendable or blocking moiety
• CPC Class Codes: C12Q 2533/101 Primer extension
• CPC Class Codes: C12Q 2537/163 blocking probe

Abstract

Novel methods of synthesizing multiple copies of a target nucleic acid sequence which are autocatalytic are disclosed (i.e., able to cycle automatically without the need to modify reaction conditions such as temperature, pH, or ionic strength and using the product of one cycle in the next one). In particular, methods of nucleic acid amplification are disclosed which are robust and efficient, while reducing the appearance of side-products. In general, the methods use priming oligonucleotides that target only one sense of a target nucleic acid, a promoter oligonucleotide modified to prevent polymerase extension from its 3′-terminus and, optionally, a means for terminating a primer extension reaction, to amplify RNA or DNA molecules in vitro, while reducing or substantially eliminating the formation of side-pro ducts. The disclosed methods minimizes or substantially eliminate the emergence of side-products, thus providing a high level of specificity. Furthermore, the appearance of side-products can complicate the analysis of the amplification reaction by various molecular detection techniques. The disclosed methods minimize or substantially eliminate this problem, thus providing enhanced levels of sensitivity.

Claims

1. A method of synthesizing multiple copies of a target sequence, said method comprising:

treating a target nucleic acid comprising a DNA target sequence with a priming oligonucleotide which hybridizes to the 3′

-end of said target sequence such that a primer extension reaction can be initiated therefrom, wherein said priming oligonucleotide does not comprise RNA;

extending said priming oligonucleotide in a primer extension reaction with a DNA polymerase to give a first DNA primer extension product, at least a portion of said first primer extension product being complementary to said target sequence;

treating said target nucleic acid with a displacer oligonucleotide which hybridizes to said target nucleic acid upstream from said priming oligonucleotide such that a primer extension reaction can be initiated therefrom;

extending said displacer oligonucleotide in a primer extension reaction with said DNA polymerase to give a second DNA primer extension product that displaces said first primer extension product from said target nucleic acid;

treating said first primer extension product with a promoter oligonucleotide comprising first and second regions, said first region comprising a base sequence which corresponds to a region at the 5′

-end of said target sequence and which hybridizes to said first primer extension product to form a promoter oligonucleotide;

first primer extension product hybrid, and said second region comprising a promoter for an RNA polymerase and situated 5′

to said first region, wherein said promoter oligonucleotide is modified to prevent the initiation of DNA synthesis therefrom;

transcribing from said promoter oligonucleotide;

first primer extension product hybrid multiple first RNA products complementary to at least a portion of said first primer extension product using an RNA polymerase which recognizes said promoter and initiates transcription therefrom, wherein the base sequences of said first RNA products are substantially identical to the base sequence of said target sequence,

provided that if said first primer extension product has a defined 3′

-end, then said method further comprises treating said target nucleic acid with a binding molecule which binds to said target nucleic acid adjacent to or near the 5′

-end of said target sequence.

2. The method of claim 1, wherein any oligonucleotide provided in said method which comprises a promoter for an RNA polymerase is modified to prevent the initiation of DNA synthesis therefrom.

3. The method of claim 1, wherein said priming oligonucleotide consists of deoxynucleotides and/or analogs thereof.

4. The method of claim 1, wherein said promoter oligonucleotide is modified to include a blocking moiety situated at its 3′

-terminus.

5. The method of claim 4, wherein said blocking moiety of said promoter oligonucleotide comprises a substituent selected from the group consisting of:

a modified nucleotide, a nucleotide or a nucleotide sequence having a 3′

-to-5′

orientation, a 3′

alkyl group, a 3′

2′

-dideoxynucleotide, a 3′

cordycepin, a 3′

alkane-diol residue, a 3′

non-nucleotide moiety, a nucleotide sequence non-complementary to said target sequence, a nucleic acid binding protein, and mixtures thereof.

6. The method of claim 1, wherein said promoter oligonucleotide further comprises an insertion sequence positioned between or adjacent to said first and second regions, and wherein the presence of said insertion sequence in said promoter oligonucleotide enhances the rate at which said RNA products are formed.

7. The method of claim 1 further comprising, prior to extending said priming oligonucleotide in a primer extension reaction, exposing a double-stranded complex comprising said target nucleic acid to conditions sufficient to denature said complex.

8. The method of claim 7, wherein said conditions include heat.

9. The method of claim 1, wherein said target nucleic acid is in a double-stranded complex, and wherein said method does not comprise, prior to extending said priming oligonucleotide in a primer extension reaction, exposing said complex to conditions sufficient to denature said complex.

10. The method of claim 1 further comprising:

treating said first RNA products with said priming oligonucleotide to form a priming oligonucleotide;

first RNA product hybrid such that a primer extension reaction can be initiated from said priming oligonucleotide;

extending said priming oligonucleotide in a primer extension reaction with said DNA polymerase to give a second DNA primer extension product complementary to said first RNA product, said second primer extension product having a 3′

-end which is complementary to the 5′

-end of said first RNA product;

separating said second primer extension product from said first RNA product using an enzyme which selectively degrades said first RNA product;

treating said second primer extension product with said promoter oligonucleotide to form a promoter oligonucleotide;

second primer extension product hybrid;

extending the 3′

-end of said second primer extension product in said promoter oligonucleotide;

second primer extension product hybrid to add a sequence complementary to said second region of said promoter oligonucleotide; and

transcribing from said promoter oligonucleotide;

second primer extension product hybrid multiple second RNA products complementary to said second primer extension product using said RNA polymerase, wherein the base sequences of said second RNA products are substantially identical to the base sequence of said target sequence.

11. The method of claim 10, wherein said priming oligonucleotide is extended using a reverse transcriptase having an RNAse H activity.

12. The method of claim 10, wherein said enzyme has an RNAse H activity, and wherein said enzyme is other than a reverse transcriptase.

13. The method of claim 1, wherein the activity of said DNA polymerase in said method is substantially limited to the formation of said first and second primer extension products.

14. The method of claim 1, wherein a 5′

-region of said displacer oligonucleotide includes one or more modifications for increasing the binding affinity of said displacer oligonucleotide for said target nucleic acid, and wherein said modifications do not prevent said displacer oligonucleotide from being extended in a primer extension reaction.

15. The method of claim 14, wherein said modifications are spaced at least 15 bases from the 3′

-terminus of said displacer oligonucleotide.

16. The method of claim 14, wherein said modifications are LNAs.

17. The method of claim 1, wherein said displacer oligonucleotide hybridizes to said target nucleic acid such that the 3′

-terminal base of said displacer oligonucleotide is adjacent to the 5′

-terminal base of said priming oligonucleotide.

18. The method of claim 1, wherein said displacer oligonucleotide hybridizes to said target nucleic acid such that the 3′

-terminal base of said displacer oligonucleotide is spaced from 5 to 35 bases from the 5′

-terminal base of said priming oligonucleotide.

19. The method of claim 1, wherein said target nucleic acid is treated with said priming oligonucleotide prior to treating said target nucleic acid with said displacer oligonucleotide.

20. The method of claim 1, wherein said first primer extension product is formed prior to treating said target nucleic acid with said displacer oligonucleotide.

21. The method of claim 1, wherein said target nucleic acid is treated with said priming oligonucleotide and said displacer oligonucleotide prior to exposing said target nucleic acid to a DNA polymerase.

22. The method of claim 1 further comprising treating the 3′

-end of at least one of said priming oligonucleotide and said displacer oligonucleotide with one or more caps, each said cap comprising a base region complementary to at least 3 bases at the 3′

-end of said priming oligonucleotide or said displacer oligonucleotide, wherein the 5′

-terminal base of each said cap is complementary to the 3′

-terminal base of said priming oligonucleotide or said displacer oligonucleotide, and wherein each said cap is modified to prevent the initiation of DNA synthesis therefrom.

23. The method of claim 22, wherein each said cap is complementary to no more than 8 bases at the 3′

-end of said priming oligonucleotide or said displacer oligonucleotide.

24. The method of claim 22, wherein each said cap prevents non-specific hybridization between said priming oligonucleotide or said displacer oligonucleotide and said promoter oligonucleotide when each said cap is hybridized to said priming oligonucleotide or said displacer oligonucleotide.

25. The method of claim 22, wherein each said cap is a capping oligonucleotide modified to include a blocking moiety situated at its 3′

-terminus.

26. The method of claim 22, wherein the 3′

-end of at least one of said caps is covalently attached to the 5′

-end of said priming oligonucleotide or said displacer oligonucleotide, and wherein said at least one cap hybridizes to the 3′

-end of said priming oligonucleotide or said displacer oligonucleotide by forming a loop.

27. The method of claim 26, wherein said at least one cap is joined to said priming oligonucleotide or said displacer oligonucleotide via a linker region.

28. The method of claim 27, wherein said linker region comprises at least 5 nucleotides.

29. The method of claim 27, wherein said linker region comprises at least 5 abasic nucleotides.

30. The method of claim 1 further comprising:

treating said target nucleic acid with said binding molecule; and

extending the 3′

-end of said first primer extension product in said promoter oligonucleotide;

first primer extension product hybrid to add a sequence complementary to said second region of said promoter oligonucleotide.

31. The method of claim 30, wherein said binding molecule comprises an oligonucleotide having a blocking moiety situated at its 3′

-terminus to prevent the initiation of DNA synthesis therefrom.

32. The method of claim 31, wherein said binding molecule comprises LNAs.

33. The method of claim 30, wherein said binding molecule is a terminating oligonucleotide.

34. The method of claim 33, wherein the 5′

-end of said terminating oligonucleotide is complementary to at least two bases at the 5′

-end of said first region of said promoter oligonucleotide.

35. The method of claim 33, wherein the 5′

-end of said terminating oligonucleotide is complementary to at least three but no more than ten bases at the 5′

-end of said first region of said promoter oligonucleotide.

36. The method of claim 30, wherein said binding molecule is a modifying oligonucleotide.

37. The method of claim 36, wherein said modifying oligonucleotide is a digestion oligonucleotide.

38. The method of claim 1 further comprising treating said first primer extension product with an extender oligonucleotide, said extender oligonucleotide hybridizing to a region of said first primer extension product 3′

to said promoter oligonucleotide of said promoter oligonucleotide;

first primer extension product hybrid, such that an extender oligonucleotide;

first primer extension product hybrid is formed.

39. The method of claim 38, wherein said extender oligonucleotide further comprises a blocking moiety situated at its 3′

terminus to prevent the initiation of DNA synthesis therefrom.

40. The method of claim 38, wherein said extender oligonucleotide hybridizes to said first primer extension product such that the 5′

-terminal base of said extender oligonucleotide is spaced within three nucleotides of the 3′

-terminal base of said promoter oligonucleotide.

41. The method of claim 38, wherein said extender oligonucleotide hybridizes to said first primer extension product adjacent said promoter oligonucleotide.

42. The method of claim 1 further comprising determining the presence or amount of said multiple copies of said target sequence.

43. The method of claim 42, wherein the presence or amount of said multiple copies of said target sequence is determined with a detection probe having a detectable label.

44. The method of claim 43, wherein the presence or amount of said multiple copies of said target sequence is determined after said first RNA products are transcribed.

45. The method of claim 43, wherein the presence or amount of said multiple copies of said target sequence is determined as said first RNA products are being transcribed.

46. The method of claim 45, wherein said probe is a self-hybridizing probe and includes a pair of interacting labels.

47. The method of claim 1, wherein said method is carried out at a substantially constant temperature.